← All medicines

Neurological medicines

Opicapone

Independent educational summary · Sources checked November 20, 2026

A COMT inhibitor used with levodopa/carbidopa for Parkinson wearing-off symptoms.

Profile scope: Opicapone. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Constipation, mouth dryness, sleep disturbance, dizziness, weight loss, or involuntary movements may occur.

Serious risks and warning signs

Hallucinations, delusions, aggressive behavior, or fainting requires prompt assessment. Enhanced levodopa effects may require a coordinated regimen adjustment. Sleepiness, blood-pressure effects, and new compulsive behavior should be discussed rather than independently changing treatment.

A question for your healthcare team

How will movements, alertness, standing blood pressure, and behavior be monitored across my full Parkinson regimen?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.